Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis

Systemic Lupus Erythematosis Clinical Trial

Official title: Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis

Status Completed

Clinical Trial Summary

This study aims to identify the expression signature of miR-181a, miR-196a and miR-21 in plasma of SLE patients and difference in their expression among groups with different systemic lupus erythematosis disease activity index (SLEDAI) scores.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic

Related Conditions & MeSH terms

• Lupus Erythematosus, Systemic
• Systemic Lupus Erythematosis

• NCT number: NCT02756546
• Study type: Interventional
• Source: Cairo University
• Status: Completed
• Phase: Phase 1/Phase 2
• Start date: September 2014
• Completion date: December 2015